A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease

PURPOSE: According to the requirements of the “Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions”, this health technology assessment provides an evidence-based basis for drug selection and rational clinical use of glucagon-like peptide-1 receptor agonist drugs in medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zeyu, Li, Jinjian, Yang, Sensen, Deng, Weishang, Chen, Jisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440721/
https://www.ncbi.nlm.nih.gov/pubmed/36065167
http://dx.doi.org/10.2147/TCRM.S375067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440721/
https://www.ncbi.nlm.nih.gov/pubmed/36065167
http://dx.doi.org/10.2147/TCRM.S375067

Ejemplares similares